1. Home
  2. NSP vs AMLX Comparison

NSP vs AMLX Comparison

Compare NSP & AMLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Insperity Inc.

NSP

Insperity Inc.

HOLD

Current Price

$53.46

Market Cap

2.0B

ML Signal

HOLD

Logo Amylyx Pharmaceuticals Inc.

AMLX

Amylyx Pharmaceuticals Inc.

HOLD

Current Price

$34.54

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NSP
AMLX
Founded
1986
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
2.0B
IPO Year
1996
2021

Fundamental Metrics

Financial Performance
Metric
NSP
AMLX
Price
$53.46
$34.54
Analyst Decision
Hold
Strong Buy
Analyst Count
3
9
Target Price
$47.67
$21.56
AVG Volume (30 Days)
446.5K
3.5M
Earning Date
04-30-2026
05-07-2026
Dividend Yield
6.45%
N/A
EPS Growth
N/A
65.46
EPS
0.97
N/A
Revenue
$6,812,000,000.00
$380,786,000.00
Revenue This Year
$3.45
N/A
Revenue Next Year
$6.95
N/A
P/E Ratio
$53.41
N/A
Revenue Growth
3.51
1612.94
52 Week Low
$18.57
$9.15
52 Week High
$57.22
$41.14

Technical Indicators

Market Signals
Indicator
NSP
AMLX
Relative Strength Index (RSI) 59.58 71.92
Support Level $47.54 $12.54
Resistance Level $55.09 $41.14
Average True Range (ATR) 2.35 2.27
MACD -0.24 0.63
Stochastic Oscillator 88.80 75.83

Price Performance

Historical Comparison
NSP
AMLX

About NSP Insperity Inc.

Insperity Inc is a company that provides a wide range of human resources and business solutions designed to help businesses improve their performance. Small and midsize enterprises are the company's primary target customers. Majority of the company's products are offered through the company's Workforce Optimization and Workforce Synchronization solutions, which comprise various human resource functions, such as payroll and employment administration, employee benefits and compensation, government compliance, performance management, training and development services, and human capital management. The company generates all of its revenue in the United States.

About AMLX Amylyx Pharmaceuticals Inc.

Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on developing novel therapies for communities with high unmet medical needs. The company has preclinical and clinical development programs in endocrine conditions and neurodegenerative diseases. Its pipeline includes investigational therapies matched with diseases based on mechanistic rationale, clinical outcomes, biomarkers, and preclinical data. The company is currently developing avexitide for Post-Bariatric Hypoglycemia, AMX0035 for Wolfram Syndrome, AMX0114 for Amyotrophic Lateral Sclerosis, and AMX0318 for Post-Bariatric Hypoglycemia and other rare diseases.

Share on Social Networks: